PT87381A - Process for the manufacture of oral forms of administration with delayed release containing carbamazepine - Google Patents

Process for the manufacture of oral forms of administration with delayed release containing carbamazepine

Info

Publication number
PT87381A
PT87381A PT87381A PT8738188A PT87381A PT 87381 A PT87381 A PT 87381A PT 87381 A PT87381 A PT 87381A PT 8738188 A PT8738188 A PT 8738188A PT 87381 A PT87381 A PT 87381A
Authority
PT
Portugal
Prior art keywords
administration
manufacture
delayed release
oral forms
release containing
Prior art date
Application number
PT87381A
Other languages
English (en)
Other versions
PT87381B (pt
Inventor
Satish Chandra Khanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT87381A publication Critical patent/PT87381A/pt
Publication of PT87381B publication Critical patent/PT87381B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
PT87381A 1987-05-04 1988-05-02 Processo para a producao de formas de administracao oral com libertacao retardada contendo carbamazepina PT87381B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH168287 1987-05-04

Publications (2)

Publication Number Publication Date
PT87381A true PT87381A (pt) 1989-05-31
PT87381B PT87381B (pt) 1992-08-31

Family

ID=4216129

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87381A PT87381B (pt) 1987-05-04 1988-05-02 Processo para a producao de formas de administracao oral com libertacao retardada contendo carbamazepina

Country Status (21)

Country Link
US (1) US5122543A (pt)
EP (1) EP0289977B1 (pt)
JP (1) JPH01131117A (pt)
KR (1) KR960006059B1 (pt)
AT (1) ATE94390T1 (pt)
AU (1) AU619178B2 (pt)
CA (1) CA1328219C (pt)
DD (1) DD269784A5 (pt)
DE (1) DE3884044D1 (pt)
DK (1) DK169608B1 (pt)
ES (1) ES2043716T3 (pt)
FI (1) FI882044A (pt)
HU (1) HU199074B (pt)
IE (1) IE63081B1 (pt)
IL (1) IL86211A (pt)
MX (1) MX11339A (pt)
NO (1) NO881933L (pt)
NZ (1) NZ224476A (pt)
PH (1) PH24895A (pt)
PT (1) PT87381B (pt)
ZA (1) ZA883135B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
DE4422881A1 (de) * 1993-10-25 1995-04-27 Bayer Ag Kolloidal dispergierbare Wirkstoff-Formulierungen
EP0788346B9 (en) * 1994-03-18 2007-02-14 Supernus Pharmaceuticals, Inc. Emulsified drug delivery systems
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
AU749301B2 (en) * 1997-12-19 2002-06-20 Taro Pharmaceutical Industries Ltd. Topical carbamazepine formulations and methods of use
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US6607784B2 (en) * 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
JP4376518B2 (ja) * 2000-12-22 2009-12-02 バクスター・インターナショナル・インコーポレイテッド サブミクロン粒子の懸濁物を調製する方法
US8067032B2 (en) * 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6951656B2 (en) * 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
IN190699B (pt) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
AU2002337692B2 (en) * 2001-09-26 2007-09-13 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US20060003012A9 (en) * 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
AU2003231919A1 (en) * 2002-03-14 2003-09-22 Sun Pharmaceutical Industries Limited Oral controlled drug delivery system containing carbamazepine
US20060280787A1 (en) * 2005-06-14 2006-12-14 Baxter International Inc. Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
CA2608930A1 (en) * 2005-06-14 2006-12-28 Baxter International Inc. Pharmaceutical formulations for minimizing drug-drug interactions
CA2628630A1 (en) * 2005-11-15 2007-05-24 Baxter International Inc. Compositions of lipoxygenase inhibitors
US20090152176A1 (en) * 2006-12-23 2009-06-18 Baxter International Inc. Magnetic separation of fine particles from compositions
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US9394327B1 (en) * 2013-03-15 2016-07-19 The Trustees Of California State University Nucleoside crystals, crystal nucleation and growth control with antifreeze proteins
WO2016081022A1 (en) * 2014-11-18 2016-05-26 PixarBio Corporation Compositions for treating acute, post-operative, or chronic pain and methods of using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
JPS59147374A (ja) * 1983-02-10 1984-08-23 Fuji Xerox Co Ltd 電子写真複写機のブラシクリ−ニング方法
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
US4548990A (en) * 1983-08-15 1985-10-22 Ciba-Geigy Corporation Crosslinked, porous polymers for controlled drug delivery
ATE78404T1 (de) * 1985-05-02 1992-08-15 Ciba Geigy Ag Hydrogele mit erhoehter beladungskapazitaet bezueglich einer in einem organischen loesungsmittel loeslichen wirksubstanz, deren herstellung sowie deren verwendung.
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
JPH0641286B2 (ja) * 1987-05-14 1994-06-01 信行 西井 自動包装装置
US4964606A (en) * 1989-10-26 1990-10-23 Ncr Corporation Overhead mount for a CRT

Also Published As

Publication number Publication date
JPH01131117A (ja) 1989-05-24
DD269784A5 (de) 1989-07-12
HU199074B (en) 1990-01-29
ES2043716T3 (es) 1994-01-01
ZA883135B (en) 1988-11-07
NZ224476A (en) 1990-09-26
FI882044A0 (fi) 1988-05-02
DK238888A (da) 1988-11-05
KR960006059B1 (ko) 1996-05-08
MX11339A (es) 1993-12-01
DE3884044D1 (de) 1993-10-21
KR880013550A (ko) 1988-12-21
HUT46847A (en) 1988-12-28
PT87381B (pt) 1992-08-31
FI882044A (fi) 1988-11-05
EP0289977A1 (de) 1988-11-09
AU619178B2 (en) 1992-01-23
US5122543A (en) 1992-06-16
IE63081B1 (en) 1995-03-22
AU1555888A (en) 1988-11-10
IL86211A (en) 1992-03-29
IE881328L (en) 1988-11-04
DK169608B1 (da) 1994-12-27
NO881933D0 (no) 1988-05-03
ATE94390T1 (de) 1993-10-15
CA1328219C (en) 1994-04-05
EP0289977B1 (de) 1993-09-15
NO881933L (no) 1988-11-07
PH24895A (en) 1990-12-26
IL86211A0 (en) 1988-11-15
DK238888D0 (da) 1988-05-03

Similar Documents

Publication Publication Date Title
PT87381A (pt) Process for the manufacture of oral forms of administration with delayed release containing carbamazepine
EP0131057A4 (en) METHOD FOR PRODUCING QUARTZ GLASS.
EP0319031A3 (en) Manufacture of a quartz glass vessel for the growth of single crystal semiconductor
DE3850686T2 (de) Ätzlösung zur Bewertung der Kristallfehler.
EP0313053A3 (en) Liquid crystal devices and process for producing the same
RO72905A (ro) Procedeu pentru prepararea unor derivati ai 1-fenil-2,3,4,5-tetrahidro-1h-3-benzazepinei
IT1216716B (it) Procedimento per produrre roux.
NO882222D0 (no) Fremgangsmaate for fremstilling av tynn film av supraledende oksyd.
DE3884856T2 (de) Verfahren zur Herstellung keramischer supraleitender Fäden.
AU2045188A (en) Crystal article, method for producing the same and semiconductor device utilizing the same
DE3879536T3 (de) Supraleitender keramischer Film und Verfahren zu dessen Herstellung.
CA970862A (en) Synchronized quartz crystal watch
PT86619A (pt) Process for preparing alkylmelatonins
RO91666A (ro) Procedeu pentru prepararea unor derivati de acid fenoxiprostatrienoic
TR23890A (tr) Saf asit borik üretimine mahsus usul.
DE3868875D1 (de) Apparat zur produktion von halbleitern.
MY103367A (en) Oral forms of administration with delayed release
JPS5228258A (en) Method for growth of crystals from liquid phase
DE3880479T2 (de) Fluessigkristallmischung.
NO883268D0 (no) Apparat for innoevelse av hjerte-lunge-gjenoppliving.
CA901079A (en) Method of producing single crystals of semiconductor material by floating-zone melting, semiconductor single crystal produced by said method and device for carrying out the same
EG18022A (en) The process for producing,liquid fertelizers in high concentration solution
DK0747340T3 (da) Vandfrit trinatriumcitrat, fremgangsmåde til fremstilling deraf og dets anvendelse som bærermateriale
JPS5280299A (en) Furnace for synthesizing artificial rock crystal
IS3225A7 (is) Aðferð til þess að framleiða ljósfræðilega hreina blöndu

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920213

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960831